Research has demonstrated that via controlling the ERK/MAPK signaling pathway and specifically targeting MEK1, miR-101 regulates cell proliferation and apoptosis in DLBCL [46]. This evidence concerns the gene MAP2K1 and diffuse large B-cell lymphoma.